Latest Headlines

Latest Headlines

Team tackles therapeutic Parkinson's vax

Investigators engaged in preclinical studies have already seen how blocking a particular protein can reduce the level of nerve damage associated with Parkinson's disease. Now researchers at the

Merck resumes sale of all its child vaccines

Merck (NYSE: MRK) says that for the first time since 2007, its entire lineup of pediatric vaccines is available--a milestone in the company's efforts to recover from a series of vaccine manufacturing

Studies advocate use of GSK, Merck vaccines

Trials in Asia and Africa show rotavirus vaccines can save the lives of even the poorest young children and programs should begin to vaccinate as many as possible, researchers say. Report

Scientists working on chronic stress vax

Stanford scientists may be on the verge of a vaccine to combat chronic stress. For 30 years, Dr. Robert Sapolsky, a neuroscience professor at Stanford, has been studying stress, and now he and his

Merck, Sanofi outline plans for new animal health JV

The newly created Merial-Intervet is being forged by Merck and Sanofi-Aventis into a global powerhouse in the animal health industry, and it will rely heavily on income from some best-selling

How Novartis Vaccines turned fear into function

To hear Novartis Vaccines & Diagnostics' head of technical ops tell it, fear was the enemy when Novartis swept into its newly acquired vaccine company, Chiron. And conquering that fear was what

Smallpox vaccinia virus spread by physical contact

For the fifth time in the past year, a woman who had sexual contact with a member of the U.S. military contracted the vaccinia virus after being exposed to the puncture site for a smallpox vaccine.

Study: No benefit to spreading out vaccines

University of Louisville researchers have determined that there is no benefit to delaying immunizations during the first year of life. The study, which was published in the journal Pediatrics, looked

Simcere unit fined $3.7M for substandard vaccines

Simcere Pharmaceutical Group announced Monday that Chinese officials have imposed a $3.75 million fine on its Jiangsu Yanshen unit as a result of its production of substandard rabies vaccine for

Fungi, caterpillars, plants, bacteria: New frontiers in vaccine production

CHANTILLY, VA- A popular topic at the World Vaccines Congress was cell-based alternatives to egg-based technologies, which was called the next frontier by Dr. Richard Schwartz of NIAID. In recent